£175.38

Springer Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 74 days • 74 data points (No recent data available)

Historical
Generating forecast...
£175.38 £145.83 £152.28 £158.73 £165.17 £171.62 £178.07 25 January 2026 12 February 2026 02 March 2026 20 March 2026 08 April 2026

Price Distribution

Price distribution over 74 days • 4 price levels

Days at Price
Current Price
30 days 14 days 13 days 17 days · current 0 8 15 23 30 £149 £172 £174 £175 Days at Price

Price Analysis

Most common price: £149 (30 days, 40.5%)

Price range: £149 - £175

Price levels: 4 different prices over 74 days

Description

Previous volumes in this series have discussed the current progression have identified a variety of targets and strategies state of our knowledge concerning the pathophysiology of to allow these goals to be realized. This volume critically cancer growth and progression. The complexity of the in reviews approaches towards cancer management in man at teraction of malignant neoplasms and the host, the the levels of: detection, diagnosis, surgery, radiology, heterogeneity of malignant cell subpopulations, and the chronobiology and endocrine treatment. existence of metastatic tumor cells resistant to drug thera Several chapters review selected methods of cancer diag pies remain as significant clinical challenges to clinical on nosis. In addition, a variety of on-going and novel ap cologists. Indeed, conventional treatment regimens of che proaches for cancer treatment are also presented in this volume. Progress in the early detection of malignant neo motherapy, surgery and radiology are often ineffective for the therapy of a large variety of established metastatic can plasms, coupled with novel approaches for the therapy of cer in patients. When one considers the insidiousness of such neoplasms, may ultimately yield safe and well-tolerated agents for the selective therapy of solid malignancies. New progressive neoplastic growth and the emergence of con tinuously more aggressive and malignant cellular subpop therapeutic approaches, directed towards the biochemical ulations one is overwhelmed with the challenges inherent in and molecular targets identified in the earlier volumes of this series, may ultimately lead to the generation of new mo attempting to control malignant neoplasms.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
05 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
99% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
95% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£110.00 10 Mar 2026
Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)
94% match

Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)

Springer

£93.06 10 Mar 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
94% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Springer

£165.82 14 Jan 2026
Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens: 54 (Cancer Treatment and Research, 54)
94% match

Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens: 54 (Cancer Treatment and Research, 54)

Springer

£104.20 12 Jan 2026
Etiology of Cancer in Man: 6 (Cancer Growth and Progression, 6)
94% match

Etiology of Cancer in Man: 6 (Cancer Growth and Progression, 6)

Springer

£176.28 14 Apr 2026
New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)
94% match

New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)

Springer

£84.55 09 Jan 2026
Experimental and Clinical Metastasis: A Comprehensive Review
94% match

Experimental and Clinical Metastasis: A Comprehensive Review

Springer

£60.00 02 Mar 2026
Concise Manual of Hematology and Oncology
94% match

Concise Manual of Hematology and Oncology

Springer

£135.17 24 Jan 2026
Springer Cancer Chemotherapy Volume 36 - Research Series
94% match

Springer Cancer Chemotherapy Volume 36 - Research Series

Springer

£113.25 05 Mar 2026
Springer Cancer Chemotherapy Vol 36 - Clinical Developments
94% match

Springer Cancer Chemotherapy Vol 36 - Clinical Developments

Springer

£129.94 04 Mar 2026
Advances in Respiratory Cancerogenesis: 911 (Advances in Experimental Medicine and Biology, 911)
94% match

Advances in Respiratory Cancerogenesis: 911 (Advances in Experimental Medicine and Biology, 911)

Springer

£74.71 24 Feb 2026
Oncogenes: 47 (Cancer Treatment and Research, 47)
94% match

Oncogenes: 47 (Cancer Treatment and Research, 47)

Springer

£148.77 25 Jan 2026
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
94% match

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Springer

£174.99 25 Jan 2026
Concise Manual of Hematology and Oncology
94% match

Concise Manual of Hematology and Oncology

Springer

£39.24 05 Apr 2026
From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)
94% match

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Springer

£149.65 30 Mar 2026
Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)
94% match

Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)

Humana

£219.73 09 Apr 2026
Molecular Biology of Human Cancers
94% match

Molecular Biology of Human Cancers

£76.67 12 Jan 2026
Molecular Biology of Human Cancers
94% match

Molecular Biology of Human Cancers

£96.11 13 Jan 2026
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
94% match

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Springer

£149.65 14 Apr 2026
Springer - Signaling Pathways and Molecular Mediators in Metastasis
93% match

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Springer

£114.94 20 Apr 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
93% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£82.73 09 Mar 2026
UICC Manual of Clinical Oncology
93% match

UICC Manual of Clinical Oncology

Wiley

£119.69 06 Feb 2026
Late Sequelae in Oncology (Medical Radiology)
93% match

Late Sequelae in Oncology (Medical Radiology)

Springer

£77.90 08 Mar 2026